Therefore, increasing the synaptic levels of ACh in the brain by inhibiting the acetylcholinesterase (AChE) enzyme, which is primarily responsible for its hydrolysis and termination of action, is the most promising method for the symptomatic treatment of AD [7]. The gene discussed is ACHE; the disease is Alzheimer disease.